Skip to Main Content

Paper Details

Prospective Clinical Genomic Profiling of Ewing Sarcoma: <i>ERF</i> and <i>FGFR1</i> Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic Relevance.
JCO Precis Oncol
2
2022
Author NameAffiliation
Richard KocheCenter for Epigenetics Research, Memorial Sloan Kettering Cancer Center
Richard KocheCenter for Epigenetics Research, Memorial Sloan Kettering Cancer Center
Elisa de StanchinaMemorial Sloan Kettering Cancer Center
Charles L SawyersMemorial Sloan Kettering Cancer Center
Charles L SawyersMemorial Sloan Kettering Cancer Center
Rohit BoseUniversity of California san francisco
Rohit BoseUniversity of California san francisco
Rohit BoseUniversity of California san francisco
Rohit BoseHelen Diller Family Comprehensive Cancer Center
Marc LadanyiMemorial Sloan Kettering Cancer Center
Marc LadanyiMemorial Sloan Kettering Cancer Center
  • 1 - 11

Datasets

Release 1.2